Interferometric phase-contrast X-ray CT imaging of VX2 rabbit cancer at 35keV X-ray energy by Takeda Tohoru et al.
Interferometric phase-contrast X-ray CT
imaging of VX2 rabbit cancer at 35keV X-ray
energy
著者 Takeda Tohoru, Wu Jin, Tsuchiya Yoshinori,
Yoneyama Akio, Lwin Thet-Thet, Hyodo Kazuyuki,
Itai Yuji
journal or
publication title
AIP conference proceedings
volume 705
page range 1328-1331
year 2004-05-12
権利 (C)2004 American Institute of Physics
URL http://hdl.handle.net/2241/89265
doi: 10.1063/1.1758046
Interferometric phase-contrast X-ray CT imaging of
　　　VX2 rabbit cancer at 35keV x-ray energy
　　　　Tohoru takeda＼ JinべNIJ＼Yoshinori TSUCHIYA^ ，
　Akio YONEYAMA^ ＴＨＥＴ-ＴＨＥＴ-LAVI‾NI，ＫａｚｕｙｕｋｉHYODO^
　　　　　　　　　　　　　　Yuji ITAI^
　Ｉ Ｉｎｓｔitｕｔｅ ｏｆ Ｃｌｉｎｉｃａｌ Ｍｅｄｉｃｉｎｅ， Ｕｎｉｖｅｒｓｉｔｙ　of　Ｔｓｕkｕｂａ，　Ｔｓｕｋｕｂａ-ｓhi， Ｉｂｏｒａｋｉ ３０５-８５７５， Ｊａｐａｎ
　　　^Advanced /をsearchむ治θΓαzθΓy， Hitachi,£td , Hatoyama, Saitama, 350-０3９５ Ｊａｐａｎ
^Material Structure Sciを^nce, High£nergy Accelびαだw ReseaΓch Orgamza政弘7'y£4だ£冶αjθj-０８０1
　　　　　　　　　　　　　　　　　　　　　　　　Ｊａｐａｎ
Abstract. Imaging of large objects at 17 7-keV low x-ray energy causes huge x-ray exposure to the
objects even using lnterferometnc phase-contrast x-ray CT (ＰＣＣＴ)Thｕs，we tned to obtain PCCT images
at high x-ray energy of 3 5keV and examined the image quality using ａformahn-fixed VX2 rabbit cancer
specimen with 15-mm ｍ diameter The PCCT system consisted of an asymmetrically cut silicon(220)
crystal.ａ monolithic x-ray interferometer, a phase-shifter,an object cell and an x-ray CCD camera The
PCCT at 35 keV clearly visualized vanous inner structures of VX2 rabbit cancer such as necrosis, cancer,
the surrounding tumor vessels, and normal liver tissue　Besides, image-contrast was not degraded
significantly　These results suggest that the PCCT at 35 KeV IS sufficient to clearly depict the
histopathological morphology of VX2 rabbit cancer specimen
1. INTRODUCTION
　　Phase-contrast x-ray imaging with an x-ray interferometer[1], has a great potential to reveal the
structures inside soft tissues without using a contrast agent because this technique has more than 1000-
fold higher sensitivity than that of the conventional absorption-contrast method [2,3]Phase-contrast ｘ-
ray ＣＴ(ＰＣＣＴ)[4]at 17 7keV x-ray energy clearly demonstrates rabbit cancer lesions [5,6]and human
cancer lesions [ﾌｰ11], however the size of these samples IS limited to less than 10-mm ｍ diameter To
observe larger biomedical objects, phase-contrast x-ray imaging systems with a large monolithic x-ray
interferometer[12]and two-crystal x-ray interferometer [13,14], have been developed A field view of
25 mm ｘ ２５ mm can be obtained at 17 7 keV and clear projection images can be depicted [12-15]
However, for imaging large objects. low x-ray energy causes huge x-ray exposure to the objects In
addition, the drift of interference fringe was generated by long data acquisition on PCCT because the
projection number must be increased to obtain adequate spatial resolution and the longer data
acquisition per pr(!jection IS required to obtain ａ sufficient signal-to-noise ratio of image (2 4-fold m
17 7 keV) (Table 1) Thus, we performed the PCCT at high x-ray energy of 35 keV to attest the
obtainability of CT images with ａ good contrast
　TABLE Ｉ. Parameters of PCCT data acquisition
Thickness Data acquisition timeX-rayenergy
(keV)
17 7keV(l 1)
15
17
25
25
x-ray absorption
by o!!jectcell
　　　1/6 5
　　　1/15 6
Projection
number
-
　250
　400
50
120
６５
Energy (mass absorption coefficientof water ｃｍ２/g)
Data acquisition time (s/projection)means x-ray exposure time per pr(!jection
Total data acquisition time included the time required for the mechanical movement of object and data transfer
time from CCD camera to computer
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２ ]METHODS AND MATERIAL
　　The phase-contrast x-ray imaging system consisted of an asymmetrically cut silicon (220) crystal,ａ
monolithic x-ray interferometer, a phase-shifter, an object cell and an x-ray CCD camera (Fig Ｄ The
study was performed at a 3-pole 5-Ｔ superconducting vertical wiggler beam line of the Photon Factory
ｍ Tsukuba, Japan The x-ray energy was set at 35 keV The beam exposure time was 50 sec/prc!jection
for 400 pr(!jections over 1 80 degrees Details of the image reconstruction methods have been previously
described[4]
　　The object was ａ formalin-fixed VX2 rabbit cancer specimen with 1 5-mm ｍ diameter It was placed
m a 25-mm-thick sample cellｍ the beam path between mirror and analyzer of the interferometer
　　The regional d6 of sample, which had been normalized by water [9], was measured on typical
necrosis, cancer and normal liver of the phase-contrast CT image　Image-contrast ratios for these
pathological lesions were calculated as pathological lesion d6 value / normal liver d6 value Data were
expressed as means 土standard deviation　Differences between the groups were analyzed using
Student's unpaired t test A p value ｏｆく005 was considered statisticallysignificant
　　The present study was approved by the Medical Committee for the Use of Animals ｍ Research of
the University of Tsukuba, and It was done ｍ conformity to the guidelines of the American
Physiological Society
FIGURE.1 A pictureof phase-contrast x-ray imaging system with ａmonolithic x-ray interferometer
　　　　　　　Inset　Setup of CT ｏt!ject
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　　　　　　　　　　　　　3. RESULTS AND DISCUSSIONS
　　Interferometnc PCCT image obtained at 35keV x-ray energy clearly demonstrated various
structures of VX2 rabbit cancer such as necrosis. cancer, the surrounding tumor vessels, and normal
liver tissue (Fig 2) Necrosis was seen as a high refractive index and cancer was seen as a relatively low
refractive index as reported ｍ ａ previous study [5-10], and the reconstructed 3-dimensional image well
visualized the localization of cancer Quantitative analysis showed that the image-contrast ratio against
normal liver was 0 79 ±0 ０７ｍ cancer and 1 3 1 ±0 １６ｍ necrosis (Fig.3), and these values were
approximately similar to the value obtained at 17 7 keV ｍ ａprevious study [9]
　　The use of high X-ray energy, when compared with 18 keV, reduced the sensitivity slightly,
however. the sensitivity obtainable at 35 keV was stillmore than 1000-fold higher than that ｍ the
absorption-contrast method (Fig 4) Image quality at 35 keV x-ray energy was not affected significantly
by visual inspection and quantitative analysis in this study However, further studies on image contrast
at high x-ray energy should be conducted to validate the clinical significance
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FIGURE.2 Phase-contrast CT image and Three dimensional image of a VX2 rabbit cancer with 15-mm ｍ
　　　　　　diameter
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FIGURE.3 A graph of the relative
image contrast ratio of pathological
lesions against normal liver portion
VX2 cancer
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FIGURE.4 A graph showing
sensitivitiesat l7 7 KeV and 35
keV x-ray energy
　　　　　　　　　　　　　　　　　Atomic number
　　The observable blurriness on CT images IS determined by the instability of interference fringes The
acquisition of image data at 3 5 keV was fairly difficult because the stability time of interference fringe
became shorter than that at 17 7 keV, and this causes image blurred To improve this problem, x-ray
CCD camera with high-speed data acquisition system must be used ｍ place of the present x-ray
detector[16]
　　In conclusion, without the aid of any contrast agent, the PCCT imaging at 3 5 keV clearly depicted
histopathological morphology of VX2 hepatic cancer with the clarify comparable to images at 1 7 7 keV
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